NO20023737D0 - Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse - Google Patents

Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse

Info

Publication number
NO20023737D0
NO20023737D0 NO20023737A NO20023737A NO20023737D0 NO 20023737 D0 NO20023737 D0 NO 20023737D0 NO 20023737 A NO20023737 A NO 20023737A NO 20023737 A NO20023737 A NO 20023737A NO 20023737 D0 NO20023737 D0 NO 20023737D0
Authority
NO
Norway
Prior art keywords
preparations
treatment
methods
inflammatory disorder
disorder
Prior art date
Application number
NO20023737A
Other languages
English (en)
Other versions
NO20023737L (no
Inventor
Elizabeth Keating
James M Kanagy
Original Assignee
Smithkline Beecham Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Co filed Critical Smithkline Beecham Co
Publication of NO20023737D0 publication Critical patent/NO20023737D0/no
Publication of NO20023737L publication Critical patent/NO20023737L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20023737A 2000-02-08 2002-08-07 Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse NO20023737L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18087900P 2000-02-08 2000-02-08
PCT/US2001/003972 WO2001058441A1 (en) 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease

Publications (2)

Publication Number Publication Date
NO20023737D0 true NO20023737D0 (no) 2002-08-07
NO20023737L NO20023737L (no) 2002-09-27

Family

ID=22662062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023737A NO20023737L (no) 2000-02-08 2002-08-07 Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse

Country Status (16)

Country Link
EP (1) EP1253919A4 (no)
JP (1) JP2003522142A (no)
KR (1) KR20020073577A (no)
CN (1) CN1398181A (no)
AU (1) AU7205701A (no)
BR (1) BR0108087A (no)
CA (1) CA2398184A1 (no)
CZ (1) CZ20022682A3 (no)
HK (1) HK1051319A1 (no)
HU (1) HUP0300689A3 (no)
IL (1) IL150963A0 (no)
MX (1) MXPA02007688A (no)
NO (1) NO20023737L (no)
PL (1) PL356447A1 (no)
WO (1) WO2001058441A1 (no)
ZA (1) ZA200206252B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338971B2 (en) 2001-08-30 2008-03-04 El-Naggar Mawaheb M Treatment of inflammatory, cancer, and thrombosis disorders
DK1429807T3 (da) * 2001-09-19 2007-06-18 Altana Pharma Ag Kombination af et NSAID og en PDE4-inhibitor
SK1862004A3 (en) * 2001-10-31 2004-08-03 Type 4 phosphodiesterase inhibitors and uses thereof
WO2004098605A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
WO2005020926A2 (en) * 2003-08-28 2005-03-10 Pharmacia Corporation Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors
CA2753597A1 (en) * 2009-02-27 2010-09-02 Boehringer Ingelheim International Gmbh Drug combinations containing pde4-inhibitors and nsaids
US9161927B2 (en) * 2009-02-27 2015-10-20 Boehringer Ingelheim International Gmbh Drug combinations containing PDE4 inhibitors and NSAIDs
SI2593452T1 (sl) 2010-07-14 2017-06-30 Novartis Ag Heterociklične spojine agonisti receptorja IP
ES2565826T3 (es) 2012-01-13 2016-04-07 Novartis Ag Pirroles fusionados como agonistas del receptor IP para el tratamiento de hipertensión arterial pulmonar (PAH) y trastornos relacionados
WO2014125413A1 (en) 2013-02-13 2014-08-21 Novartis Ag Ip receptor agonist heterocyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061779A (en) * 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
SK279958B6 (sk) * 1992-04-02 1999-06-11 Smithkline Beecham Corporation Zlúčeniny s protialergickým a protizápalovým účink
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
FR2753706B1 (fr) * 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
CN1398181A (zh) 2003-02-19
CZ20022682A3 (cs) 2003-09-17
JP2003522142A (ja) 2003-07-22
WO2001058441A1 (en) 2001-08-16
IL150963A0 (en) 2003-02-12
MXPA02007688A (es) 2002-12-13
NO20023737L (no) 2002-09-27
EP1253919A4 (en) 2007-03-14
ZA200206252B (en) 2003-08-26
CA2398184A1 (en) 2001-08-16
BR0108087A (pt) 2002-10-29
KR20020073577A (ko) 2002-09-27
PL356447A1 (en) 2004-06-28
AU7205701A (en) 2001-08-20
EP1253919A1 (en) 2002-11-06
HUP0300689A2 (hu) 2003-07-28
HUP0300689A3 (en) 2003-09-29
HK1051319A1 (zh) 2003-08-01

Similar Documents

Publication Publication Date Title
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
DE60017241D1 (de) Unterwasserbehandlungsanordnung und -verfahren
NO20011964D0 (no) Brönnbehandlingsfluider og fremgangsmåter med anvendelse derav
NO20033387D0 (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO20024610D0 (no) Synergistiske metoder og blandinger for behandling av kreft
NO20030397L (no) Amyloid målsökende billeddannende midler og anvendelser av samme
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20014314L (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20041214L (no) Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DK1381382T3 (da) Fremgangsmåder og præparater til behandling af öjensygdomme
NO20015772L (no) Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
NO20023737D0 (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
NO20023678L (no) Behandling av allergiske og inflammatoriske tilstander
DK1667693T3 (da) Præparater og fremgangsmåder til anvendelse af lamellare bodies til terapeutiske formål
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
IS6707A (is) Efnablanda til forvarna og meðhöndlunar á krabbameini

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application